Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels

Yujing Wang(China Pharmaceutical University), Zhengyu Cao(China Pharmaceutical University)
British Journal of Pharmacology
June 30, 2022
Cited by 59


Related Papers